BIOMAT Database Logo BIOMAT Database Logo

[Therapy of pulmonary embolism with calcic heparin in subcutaneous administration]. 1982

B Leoncini, and F Fabiano, and A Coli, and R Russo

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B Leoncini, and F Fabiano, and A Coli, and R Russo
[Pulmonary embolism: subcutaneous treatment with low-molecular-weight heparin?].
November 2004, Pneumologie (Stuttgart, Germany),
B Leoncini, and F Fabiano, and A Coli, and R Russo
Conjunctive heparin therapy. Limitations of subcutaneous administration.
November 1992, Circulation,
B Leoncini, and F Fabiano, and A Coli, and R Russo
[On pulmonary embolism--with a report on first experiences with subcutaneous heparin prophylaxis].
September 1967, Das Deutsche Gesundheitswesen,
B Leoncini, and F Fabiano, and A Coli, and R Russo
[Subcutaneous administration of heparin].
January 1968, Duodecim; laaketieteellinen aikakauskirja,
B Leoncini, and F Fabiano, and A Coli, and R Russo
[Incidence of pulmonary embolism at our clinic following introduction of heparin therapy by small subcutaneous doses].
February 1978, Orvosi hetilap,
B Leoncini, and F Fabiano, and A Coli, and R Russo
Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism.
June 1997, Thrombosis and haemostasis,
B Leoncini, and F Fabiano, and A Coli, and R Russo
Low-dose subcutaneous heparin decreases mortality from pulmonary embolism in patients with ischemic stroke.
January 1991, Neurologia croatica : glasilo Udruzenja neurologa Jugoslavije = official journal of Yugoslav Neurological Association,
B Leoncini, and F Fabiano, and A Coli, and R Russo
Hematoma associated with subcutaneous heparin administration.
December 1987, Focus on critical care,
B Leoncini, and F Fabiano, and A Coli, and R Russo
[A new method of heparin therapy: subcutaneous administration in thromboembolism].
February 1989, Orvosi hetilap,
B Leoncini, and F Fabiano, and A Coli, and R Russo
[Heparin in pulmonary embolism].
July 1994, Lakartidningen,
Copied contents to your clipboard!